Glycated Hemoglobin and In-Stent Restenosis Risk in Coronary Artery Disease Patients

A retrospective study of 6,297 coronary artery disease patients following percutaneous coronary intervention, examining the association between glycated hemoglobin levels and in-stent restenosis risk. The dataset includes patient stratification by HbA1c levels and logistic regression results, showing a non-linear relationship. The study was authored by Yuyang Lei and last updated in April 2026.

Use Cases

• Modeling the non-linear risk of in-stent restenosis based on HbA1c levels mentioned in the description
• Conducting stratified analyses to evaluate effect modification by clinical variables as described in the methods
• Validating threshold effect models for clinical biomarkers using the identified turning point at HbA1c 7.8%
• Training predictive models for post-PCI complications using the cohort's demographic and outcome data

Strengths

• Includes results from a cohort of 6,297 patients, providing a substantial sample size for analysis
• Reports specific statistical findings, including odds ratios and confidence intervals (e.g., OR:1.70, 95% CI 1.26–2.29)
• Employs advanced analytical methods like generalized additive models and threshold effect analysis as described

Limitations

• Column-level documentation is absent; field semantics must be inferred after download
• Row count is unknown, which may limit suitability assessment for specific modeling tasks
• The 20.2 KB file size suggests the dataset is likely a summary table or document, not a full patient-level dataset

Provenance

Source

figshare

Collection Method

Retrospective study of patient records, as described.

Time Range

null

Freshness

Last updated 2026-04-23 04:19:13; freshness should be verified

Geography

null